News

A Money-Banii interview with Balkan Pharmaceuticals' specialists

A Money-Banii interview with Balkan Pharmaceuticals' specialists

The Romanian investment - Balkan Pharmaceuticals company, launched a medication manufacturing facility in Singera, with a capacity of over 7 million packages per year.

"Investors were attracted by the location: at the intersection of the European Union and the CIS market. So Moldova is a strategic location. At the moment of the investment, taxes were attractive, as well as the fact that the wages claimed by professionals in Moldova are lower compared to the European Union. So there was a conjuncture of factors that convinced the investor to choose Moldova "- declared Vasile Cazacu, general manager of Balkan Pharmaceuticals.




The factory has an area of 10,000 m2 and was built according to GMP (Good Manufacturing Practice) international quality standards. The investments in this project are of over 30 million euros, at this stage. The factory has about 200 employees.


Source: Money-banii

IMPORTANT NOTE

11111

Due to the increasing reports of fraud using the Balkan Pharmaceuticals trademark, we inform you that:

  1. The ONLY official website of the company is https://balkanpharmaceuticals.com/
  2. Balkan Pharmaceuticals does NOT sell products through online stores and e-mails;
  3. Balkan Pharmaceuticals does NOT have offices outside of Moldova;
  4. Balkan Pharmaceuticals does NOT ship packages and does NOT request payments through Western Union, MoneyGram or other international transfer systems (SWIFT, BTC, Crypto currencies) ;
  5. All employees at Balkan Pharmaceuticals exclusively use corporate email addresses with domain @balkanpharmaceuticals.com. Please check this when responding to e-mails. Any request to make contact through other addresses is an attempt of fraud!
  6. We recommend that you learn about the latest methods of protection of Balkan Pharmaceuticals products, as well as verify the authenticity of our products, via https://b-p.md/

 Your health is a top priority for Balkan Pharmaceuticals.